analogue insulin

(redirected from analog insulin)

analogue insulin

A term of art for a synthesised insulin in which insulin’s amino acid sequence is altered by genetic engineering to alter absorption, delivery (e.g., to reduce clumping) or provide another desired characteristic.

Examples
Humulin (rapid absorption), Glargine (constant release over 24 hours).
 
Results
Evidence-based assessment indicates that they are much more expensive and do not substantially improve outcomes.
Mentioned in ?
References in periodicals archive ?
Further, premixed analog insulin is also a form of insulin which is used in diabetes.
26) The formation of stable dihexamers enables coformulation of IDeg with the glucagon-like peptide-1 receptor agonist liraglutide and the rapid-acting analog insulin aspart.
Biosimilars comprised of osteoporosis recombinant Teriparatide, analog insulin and therapeutic fragment of monoclonal antibodies
Time-action profile of the long-acting insulin analog insulin glargine (HOE901) in comparison with those of NPH insulin and placebo.
On yil once tip 1 DM tanisi konan fakat duzenli kontrollere devam etmeyen 38 yasinda kadin hasta; sabah 36u, aksam 26u bifazik hizli etkili analog insulin karisimi kullanmaktaymis.
The long-acting insulin analog insulin glargine was studied in comparison with NPH insulin in 518 patients with type 2 diabetes in an open-label, 28-week, multicenter study.
Time-action profile of the long-acting insulin analog insulin glargine (HDE901) in comparison with those of NPH insulin and placebo.
The analog insulin is available into various forms.
insulin therapy market in 2001 with the launch of Lantus, a long-acting recombinant DNA (rDNA) analog insulin for use by both types of diabetes patients.